Identification of CD123+ myeloid dendritic cells as an early-stage immature subset with strong tumoristatic potential

Cancer Letters

Volumn 270, Issue 1, 2008, Pages 19-29

  Shi, Jun ^a   Ikeda, Kazuma ^a   Maeda, Yosinobu ^a   Shinagawa, Katsuji ^a   Ohtsuka, Aiji ^a   Yamamura, Hajime ^b   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Okayama Red Cross Blood Center   (Japan)

Author keywords

CD123; Myeloid dendritic cells; TRAIL; Tumor inhibiting activity

Indexed keywords

CD123 ANTIGEN; DEATH RECEPTOR 5; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; INTERLEUKIN 4; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CARCINOGENICITY; CELL SELECTION; CELL STRUCTURE; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; APOPTOSIS; CELL DIFFERENTIATION; DENDRITIC CELLS; HL-60 CELLS; HUMANS; INTERLEUKIN-3 RECEPTOR ALPHA SUBUNIT; JURKAT CELLS; MYELOID CELLS; NEOPLASMS; RECEPTORS, INTERLEUKIN-3; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; U937 CELLS;

EID: 50649089386     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.048     Document Type: Article

References (30)

1. hereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., de Waal Malefyt R., and Liu Y.J. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
3. Zheng Z., Takahashi M., Narita M., Toba K., Liu A., Furukawa T., Koike T., and Aizawa Y. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J. Hematother. Stem Cell Res. 9 (2000) 453-464
4. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., and Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185 (1997) 1101-1111
5. Ho C.S., Munster D., Pyke C.M., Hart D.N., and López J.A. Spontaneous generation and survival of blood dendritic cells in mononuclear cell culture without exogenous cytokines. Blood 99 (2002) 2897-2904
6. Terness P., Chuang J.J., Bauer T., Jiga L., and Opelz G. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO?. Blood 105 (2005) 2480-2486
7. Ward K.A., Stewart L.A., and Schwarer A.P. CD34+-derived CD11c+++ BDCA-1++ CD123++ DC: expansion of a phenotypically undescribed myeloid DC1 population for use in adoptive immunotherapy. Cytotherapy 8 (2006) 130-140
8. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., Knop J., and Enk A.H. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur. J. Immunol. 27 (1997) 3135-3142
9. Kato T., Yamane H., and Nariuchi H. Differential effects of LPS and CD40 ligand stimulations on the induction of IL-12 production by dendritic cells and macrophages. Cell Immunol. 181 (1997) 59-67
10. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., and Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184 (1996) 747-752
11. Labeur M.S., Roters B., Pers B., Mehlinger T.A., Schwarz T., and Grabbe S. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage. J. Immunol. 162 (1999) 168-175
12. Hoffmann T.K., Meidenbauer N., Dworacki G., Kanaya H., and Whiteside T.L. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Cancer Res. 60 (2000) 3542-3549
13. Albert M.L., Sauter B., and Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392 (1998) 86-89
14. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., and Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191 (2000) 423-434
15. Chapoval A.I., Tamada K., and Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 95 (2000) 2346-2351
16. Fanger N.A., Maliszewski C.R., Schooley K., and Griffith T.S. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Exp. Med. 190 (1999) 1155-1164
17. Yang S., Darrow T.L., Vervaert C.E., and Seigler H.F. Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow. Cell Immunol. 179 (1997) 84-95
18. Josien R., Heslan M., Soulillou J.P., and Cuturi M.C. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+ dependent mechanism. J. Exp. Med. 186 (1997) 467-472
19. Zhou L.J., and Tedder T.F. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154 (1995) 3821-3835
20. Lu G., Janjic B.M., Janjic J., Whiteside T.L., Storkus W.J., and Vujanovic N.L. Innate direct anticancer effector function of human immature dendritic cells. II. Role of TNF, lymphotoxin-alpha(1)beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J. Immunol. 168 (2002) 1831-1839
21. Zhou L.J., and Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. USA 93 (1996) 2588-2592
22. Laver J., Duncan E., Abboud M., Gasparetto C., Sahdev I., Warren D., Bussel J., Auld P., O' Reilly R.J., and Moore M.A. High levels of granulocyte and granulocyte-macrophage colony-stimulating factors in cord blood of normal full-term neonates. J. Pediatr. 116 (1990) 627-632
23. O'Doherty U., Peng M., Gezelter S., Swiqqard W.J., Bhardwaj N., and Steinman R.M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82 (1994) 487-493
24. Olweus J., BitMansour A., Warnke R., Thompson P.A., Carballido J., Picker L.J., and Lund-Johansen F. Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin. Proc. Natl. Acad. Sci. USA 94 (1997) 12551-12556
25. Testa U., Fossati C., Samoggia P., Mariani G., Hassan H.J., Sposi N.M., Guerriero R., Rosato V., Gabbianelli M., Pelosi E., Valtieri M., and Peschle C. Expression of growth factor receptors in unilineage differentiation culture of purified hematopoietic progenitors. Blood 88 (1996) 3391-3406
26. So T., Lee S.W., and Croft M. Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity. Int. J. Hematol. 83 (2006) 1-11
27. Shi J., Ikeda K., Fujii N., kondo E., Shinaqawa K., Ishimaru F., Kaneda K., Tanimoto M., Li X., and Pu Q. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells. Cancer Sci. 96 (2005) 127-133
28. Liu S., Yu Y., Zhang M., Wang W., and Cao X. The involvement of TNF-alpha-related apoptosis-inducing ligand in the enhanced cytotoxicity of IFN-beta-stimulated human dendritic cells to tumor cells. J. Immunol. 166 (2001) 5407-5415
29. Vidalain P.O., Azocar O., Lamouille B., Astier A., Rabourdin-Combe C., and Servet-Delprat C. Measles virus induces functional TRAIL production by human dendritic cells. J. Virol. 74 (2000) 556-559
30. Becker Y. Dendritic cell activity against primary tumors: an overview. In Vivo 7 (1993) 187-191